Ameriprise’s Apollo Endosurgery, Inc. APEN Stock Holding History

Ameriprise’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22,002	Closed	-$121K	–	4084
2022 Q3	$121K	Sell	22,002 -4,400	-17%	-$24.4K	﹤0.01%	3797
2022 Q2	$96K	Hold	26,402	–	–	﹤0.01%	3789
2022 Q1	$160K	Buy	26,402 +1,500	+6%	+$9.14K	﹤0.01%	3790
2021 Q4	$210K	Sell	24,902 -12,500	-33%	-$109K	﹤0.01%	3778
2021 Q3	$339K	Sell	37,402 -2,300	-6%	-$19.8K	﹤0.01%	3524
2021 Q2	$322K	Buy	+39,702	New	+$272K	﹤0.01%	3615

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise's APEN Position: Q4 2022 in Review

Ameriprise sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 22,002 shares — an estimated $121K sold.

Ameriprise first reported a position in APEN in Q2 2021 and held it in 6 quarters. The position peaked at $339K in Q3 2021. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

Ameriprise reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
Ameriprise sold 22,002 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $121K.
Ameriprise first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 6 quarters.
Ameriprise's Apollo Endosurgery, Inc. position peaked at $339K in Q3 2021.
81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.